These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8242254)

  • 21. Response to atrial natriuretic peptide in dogs with acute selective intrahepatic hypertension.
    Maher E; Levy M
    Arch Int Pharmacodyn Ther; 1989; 300():231-40. PubMed ID: 2533478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of nitric oxide on cardiac hormone secretion: effect of NG-nitro-L-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release.
    Leskinen H; Vuolteenaho O; Leppäluoto J; Ruskoaho H
    Endocrinology; 1995 Mar; 136(3):1241-9. PubMed ID: 7867578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial natriuretic peptide counteracts angiotensin-II-induced impairment of renal function.
    Schafferhans K; Heidbreder E; Hummel S; Heidland A
    Z Kardiol; 1988; 77 Suppl 2():78-84. PubMed ID: 2970179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. K+ACh channel activation with carbachol increases atrial ANP release.
    Xu DY; Wen JF; Quan HX; Zhou GH; Kim SY; Park SH; Kim SZ; Lee HS; Cho KW
    Life Sci; 2008 May; 82(21-22):1083-91. PubMed ID: 18440028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypotensive response to atrial natriuretic peptide administration is enhanced with age.
    Hausdorff JM; Clark BA; Shannon RP; Elahi D; Wei JY
    J Gerontol A Biol Sci Med Sci; 1995 May; 50(3):M169-72. PubMed ID: 7743403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial natriuretic peptide prevents bronchoconstriction in vitro.
    Subratty AH
    Indian J Exp Biol; 1997 Feb; 35(2):197-9. PubMed ID: 9315228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects.
    Minette PA; Lammers JW; Dixon CM; McCusker MT; Barnes PJ
    J Appl Physiol (1985); 1989 Dec; 67(6):2461-5. PubMed ID: 2606854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial natriuretic peptide improves pulmonary gas exchange in subjects exposed to hypoxia.
    Westendorp RG; Roos AN; van der Hoeven HG; Tjiong MY; Simons R; Frölich M; Souverijn JH; Meinders AE
    Am Rev Respir Dis; 1993 Aug; 148(2):304-9. PubMed ID: 8393637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
    Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
    Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dopamine receptor antagonist haloperidol blocks natriuretic but not hypotensive effects of the atrial natriuretic factor.
    Hansell P; Fasching A; Sjöquist M; Andén NE; Ulfendahl HR
    Acta Physiol Scand; 1987 Jul; 130(3):401-7. PubMed ID: 2957892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular effects of natriuretic peptides in healthy men.
    Komarek M; Bernheim A; Schindler R; Steden R; Kiowski W; Brunner-La Rocca HP
    J Cardiovasc Pharmacol Ther; 2004 Dec; 9(4):263-70. PubMed ID: 15678245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of intracerebroventricular administration of atrial natriuretic peptide (ANP) on blood pressure, heart rate and plasma ADH and corticosterone levels in normal and dehydrated rabbits.
    Kallaras C; Angelopoulos N; Apostolakis M; Bountzioukas S; Guiba-Tziampiri O; Kontoleon-Vakalopoulou H; Mavroudis K
    J Endocrinol Invest; 1998 Apr; 21(4):200-10. PubMed ID: 9624593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal effects of atrial natriuretic peptide during dopamine infusion.
    Hirata Y; Fukui K; Hayakawa H; Suzuki E; Sugimoto T; Kimura K; Matsuoka H; Sugimoto T
    Am J Hypertens; 1990 Nov; 3(11):866-9. PubMed ID: 2175625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men.
    Hunt PJ; Espiner EA; Richards AM; Yandle TG; Frampton C; Nicholls MG
    Am J Physiol; 1995 Dec; 269(6 Pt 2):R1397-403. PubMed ID: 8594942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma and urinary digitalis-like substance levels during atrial natriuretic peptide infusion in essential hypertensive patients.
    Baldoncini R; Ferri C; Bellini C; Desideri G; De Angelis C; Santucci A
    Clin Invest Med; 1996 Feb; 19(1):13-9. PubMed ID: 8868311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blunted vascular and renal effects of exogenous atrial natriuretic peptide in patients with cushing's disease.
    Sala C; Ambrosi B; Morganti A
    J Clin Endocrinol Metab; 2001 May; 86(5):1957-61. PubMed ID: 11344191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of opioid-induced atrial natriuretic peptide release in conscious rats.
    Pesonen A; Leppäluoto J; Ruskoaho H
    J Pharmacol Exp Ther; 1990 Aug; 254(2):690-5. PubMed ID: 2143537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of human atrial natriuretic peptide on urinary sodium and urinary dopamine excretion in man.
    Struthers AD; Anderson JV; Causon RC; Christofides ND; Bloom SR
    J Hypertens Suppl; 1985 Dec; 3(3):S315-7. PubMed ID: 2856726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of atrial natriuretic peptide and amiloride on renal hemodynamics through renal kallikrein and kinins in anesthetized rabbits.
    Seino M; Abe K; Nushiro N; Omata K; Yoshinaga K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S39-42. PubMed ID: 2473347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasoconstrictor actions of atrial natriuretic peptide in the splanchnic circulation of anesthetized dogs.
    Woods RL
    Am J Physiol; 1998 Dec; 275(6):R1822-32. PubMed ID: 9843871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.